Acute bronchitis in children
Conditions
Interventions
Experimental group:Qingxuan cough granules
Control group:Pediatric pulmonary fever cough and asthma granules
Sponsors
The First Affiliated Hospital of Henan University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
4 Years to 14 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic standards of western medicine for pediatric acute bronchitis; (2) Age 4~14 years old (including boundary value), gender is not limited; (3) daytime cough symptom score = 4 or nighttime cough symptom score =4 points; (4) Within 72 hours after the onset of acute bronchitis, no drugs with cough and phlegm effect have been used before the visit; (5) The legal guardian of the child agrees that the child will participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Children with a maximum body temperature of > 38.5°C within 24 hours before enrollment; (2) Children with acute infectious diseases such as measles, pertussis, influenza, etc.; (3) Children with acute upper respiratory tract infection, bronchial asthma, bronchiolitis, wheezing bronchitis, bronchial pneumonia and other respiratory diseases; (4) Children with allergies to the study drug or its components; (5) Children with malnutrition, immune deficiency and tuberculosis; (6) Children who have participated in or are participating in clinical observation of other drugs within 1 month; (7) Children with severe primary diseases such as heart, liver, kidney, digestive and hematopoietic systems; (8) Children judged by the investigator to be unsuitable for clinical observation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical healing rate and effective rate of cough; | — |
Countries
China
Contacts
Public ContactYan Yong Bin
The First Affiliated Hospital of Henan University of Chinese Medicine
Outcome results
None listed